Results 131 to 140 of about 400,383 (291)

Viral hijacking of cellular metabolism. [PDF]

open access: yes, 2019
This review discusses the current state of the viral metabolism field and gaps in knowledge that will be important for future studies to investigate.
Ch'ng, James   +2 more
core  

Efficacy of upadacitinib induction for pediatric inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Objectives Upadacitinib, a second‐generation Janus kinase (JAK) inhibitor, is approved for moderate to severe Crohn's disease (CD) and ulcerative colitis (UC) in adults. Its efficacy in pediatric patients remains unclear, though early reports suggest benefits in refractory inflammatory bowel disease (IBD).
Evan Greenhall   +5 more
wiley   +1 more source

Inhibition of influenza virus infection by garlic oil and juice in cell culture

open access: yesJSFA reports, EarlyView.
Abstract Background Influenza virus infections are a significant global health and economic burden. Garlic (Allium sativum) has been proposed to have antimicrobial properties. Raw garlic consumption has been widely advocated on the internet to fight influenza by many public health agencies, information of which is easily accessible by the public. There
Carla Breen   +3 more
wiley   +1 more source

Lower Plasma Antioxidant Defense and Heat Shock Proteins Mark Intra‐Amniotic Sludge Ultrasound Finding

open access: yesJournal of Ultrasound in Medicine, EarlyView.
Objectives Intra‐amniotic sludge is an independent risk factor for preterm birth. It consists of a biophysical sonographic finding in the amniotic fluid, formed by dense echogenic particles near the cervical internal orifice, due to sterile or infectious inflammatory processes.
Clarissa Chavez Ortiz Roberto   +8 more
wiley   +1 more source

Assessing the Effect of Adalimumab in Granuloma Annulare: A Case Series and Literature Review

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Granuloma annulare (GA) is a benign granulomatous skin disorder for which standardized treatment guidelines are lacking due to limited evidence. Adalimumab, a TNF‐α inhibitor, shows promise as a therapeutic option due to its potential to disrupt GA granulomas.
Adriana Caixinha Valorenzos   +2 more
wiley   +1 more source

Consideraciones acerca del diagnóstico inmunilógico del síndrome TORCH Considerations about the immunologic diagnosis of TORCH syndrome

open access: yesIatreia, 1989
<p class="MsoNormal"><span style="font-size: 9pt; font-family: Arial">Se revisa someramente la epidemiología del síndrome TORCH en Colombia.
Fernando Montoya
doaj  

Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of Colchicine

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This trial was to evaluate the efficacy and the safety of colchicine for the palliative treatment of patients with primary hepatic malignancy unable to receive curative treatment. Forty hepatocellular carcinoma (HCC) patients and two intrahepatic cholangiocarcinoma (ICC) patients signed the informed consents.
Zu‐Yau Lin   +8 more
wiley   +1 more source

Editorial: Herpesvirus Maturation

open access: yesFrontiers in Microbiology, 2020
Ritesh Tandon, Jens von Einem
doaj   +1 more source

Herpes Simplex (Herpes Febrilis)

open access: yesInternational Journal of Clinical Practice, 1965
openaire   +2 more sources

Home - About - Disclaimer - Privacy